Clinical trial
Prospective Evaluation of impRoving Fluoroquinolone Exposure Using Centralized Tdm in TB Patients
NCT03409315 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of impRoving Fluoroquinolone Exposure Using Centralized Tdm in TB Patients
- Lead sponsor
- University Medical Center Groningen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 10, 2018
- Completion date
- December 31, 2020
- Enrollment
- 360 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.